Emergent BioSolutions to Participate in Investor Conferences

On August 23, 2021 Emergent BioSolutions Inc. (NYSE: EBS) repored that members of the company’s senior management team will participate in the following investor conferences (Press release, Emergent BioSolutions, AUG 23, 2021, View Source [SID1234586836]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Three Part Advisors IDEAS Midwest Conference
August 25-26, 2021
Pre-recorded presentation available on August 26; 1-on-1 meetings on August 26
Wells Fargo 2021 Virtual Healthcare Conference
September 9-10, 2021
Fireside chat on September 9 at 9:20 am ET; 1-on-1 meetings all day
Morgan Stanley 19th Annual Global Healthcare Conference
September 9-10 & 13-15, 2021
Fireside chat on September 9 at 3:30 pm ET; 1-on-1 meetings all day
Baird’s 2021 Global Healthcare Conference
September 14-15, 2021
Fireside chat on September 14 at 4:55 pm ET; 1-on-1 meetings all day
Singular Research Compelling Values Webinar
September 16, 2021
Company presentation schedule will be posted on website
Cantor 2021 Virtual Global Healthcare Conference
September 27-30, 2021
Fireside chat on September 27 at 4:00 pm ET; 1-on-1 meetings all day
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcast will be available both live, if possible, and by replay, and will be accessible from the Emergent website.